Professor Gilda Tachedjian is a NHMRC Senior Research Fellow and Heads the Life Sciences Discipline and Retroviral Biology and Antivirals Laboratory at the Burnet Institute. She is internationally recognized for her contributions to HIV reverse transcriptase, antivirals, drug resistance and HIV prevention research. She obtained her PhD in Microbiology from Monash University and completed a CJ Martin Postdoctoral Fellowship at Columbia University and an RD Wright Fellowship at the Burnet Institute. She was awarded the Frank Fenner Award by the Australian Society for Microbiology in 2012 in recognition of her distinguished contributions. Her current research interests include the development of novel drug class for HIV treatment and prevention, understanding the impact of vaginal microbiota on susceptibility to HIV and other sexually transmitted infections, and the study of intrinsic intracellular antiviral proteins in a major mammalian viral reservoir able to control viral pathogens that are lethal to humans.
Abstracts this author is presenting: